They discovered that both LIN28A and LIN28B expression promote tumor initiation, but LIN28B-induced tumors more frequently progressed to advanced adenocarcinomas in intestinal tissues and in a genetic mouse model. Here, LIN28B is linked to adenocarcinoma.